Stephanie M Rangel Selected Research

Stephanie M Rangel Research Topics

6	Infections 03/2023 - 01/2014
4	Pneumonia (Pneumonitis) 06/2015 - 06/2014
3	Ichthyosis (Xeroderma) 03/2023 - 01/2022
3	Drug-Related Side Effects and Adverse Reactions 09/2020 - 10/2018
2	Vitiligo 01/2024 - 01/2019
2	Atopic Dermatitis (Atopic Eczema) 01/2023 - 09/2018
1	Skin Diseases (Skin Disease) 01/2024
1	Keloid 09/2023
1	Eczema 04/2023
1	Fatigue 04/2023
1	Pain (Aches) 04/2023
1	Mycoses (Diseases, Fungus) 03/2023
1	Alopecia Areata 03/2023
1	Alopecia (Baldness) 03/2023
1	Inflammation (Inflammations) 01/2023
1	Epidermolytic Hyperkeratosis (Bullous Congenital Ichthyosiform Erythroderma) 01/2022
1	Netherton Syndrome 01/2022
1	Lamellar Ichthyosis (Harlequin Ichthyosis) 01/2022
1	Congenital Ichthyosiform Erythroderma 01/2022
1	Hyperkalemia 07/2019
1	Acne Vulgaris 07/2019
1	Melanoma (Melanoma, Malignant) 10/2018
1	Staphylococcal Infections 09/2018
1	Healthcare-Associated Pneumonia 02/2016

3	Proteins (Proteins, Gene)FDA Link 01/2023 - 06/2014
3	Anti-Bacterial Agents (Antibiotics)IBA 09/2018 - 11/2014
3	ADP Ribose Transferases (ADP Ribosyltransferase)IBA 06/2015 - 06/2014
2	Interleukin-17 (Interleukin 17)IBA 03/2023 - 01/2023
2	Antimicrobial PeptidesIBA 10/2022 - 09/2018
2	Type III Secretion SystemsIBA 02/2016 - 11/2014
1	CollagenIBA 09/2023
1	Immunoglobulin A (IgA)IBA 04/2023
1	SaltsIBA 03/2023
1	secukinumabIBA 03/2023
1	delgocitinibIBA 03/2023
1	Biomarkers (Surrogate Marker)IBA 01/2023
1	InterleukinsIBA 01/2023
1	RNA (Ribonucleic Acid)IBA 01/2022
1	Immune Checkpoint InhibitorsIBA 09/2020
1	PotassiumIBA 07/2019
1	Spironolactone (Aldactone)FDA LinkGeneric 07/2019
1	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 10/2018
1	Mupirocin (Bactroban)FDA LinkGeneric 09/2018
1	LipidsIBA 09/2018
1	Local Anti-Infective Agents (Antiseptics)IBA 09/2018
1	GTPase-Activating Proteins (GTPase-Activating Protein)IBA 06/2015
1	Virulence Factors (Pathogenicity Factors)IBA 01/2014
1	Fas Ligand Protein (Fas Ligand)IBA 01/2014
1	PlasminogenIBA 01/2014